CAN WE REDUCE CARDIOVASCULAR RISK IN PATIENTS WITH OBESITY?

Skoči na glavni sadržaj

Fizikalna i rehabilitacijska medicina, Vol. 40 No. 1, 2026.

Sažetak sa skupa

https://doi.org/10.21751/FRM-40-1-24

CAN WE REDUCE CARDIOVASCULAR RISK IN PATIENTS WITH OBESITY?

Jasmina Ćatić *
Dijana Bešić
Marin Viđak
Šime Manola
Ivana Jurin

* Dopisni autor.

Puni tekst: hrvatski pdf 81 Kb

str. 103-105

preuzimanja: 57

APA 6th Edition

Ćatić, J., Bešić, D., Viđak, M., Manola, Š. i Jurin, I. (2026). CAN WE REDUCE CARDIOVASCULAR RISK IN PATIENTS WITH OBESITY?. Fizikalna i rehabilitacijska medicina, 40 (1), 105-106. https://doi.org/10.21751/FRM-40-1-24

MLA 8th Edition

Ćatić, Jasmina, et al. "CAN WE REDUCE CARDIOVASCULAR RISK IN PATIENTS WITH OBESITY?." Fizikalna i rehabilitacijska medicina, vol. 40, br. 1, 2026, str. 105-106. https://doi.org/10.21751/FRM-40-1-24. Citirano 18.05.2026.

Chicago 17th Edition

Ćatić, Jasmina, Dijana Bešić, Marin Viđak, Šime Manola i Ivana Jurin. "CAN WE REDUCE CARDIOVASCULAR RISK IN PATIENTS WITH OBESITY?." Fizikalna i rehabilitacijska medicina 40, br. 1 (2026): 105-106. https://doi.org/10.21751/FRM-40-1-24

Harvard

Ćatić, J., et al. (2026). 'CAN WE REDUCE CARDIOVASCULAR RISK IN PATIENTS WITH OBESITY?', Fizikalna i rehabilitacijska medicina, 40(1), str. 105-106. https://doi.org/10.21751/FRM-40-1-24

Vancouver

Ćatić J, Bešić D, Viđak M, Manola Š, Jurin I. CAN WE REDUCE CARDIOVASCULAR RISK IN PATIENTS WITH OBESITY?. Fizikalna i rehabilitacijska medicina [Internet]. 2026 [pristupljeno 18.05.2026.];40(1):105-106. https://doi.org/10.21751/FRM-40-1-24

IEEE

J. Ćatić, D. Bešić, M. Viđak, Š. Manola i I. Jurin, "CAN WE REDUCE CARDIOVASCULAR RISK IN PATIENTS WITH OBESITY?", Fizikalna i rehabilitacijska medicina, vol.40, br. 1, str. 105-106, 2026. [Online]. https://doi.org/10.21751/FRM-40-1-24

Sažetak

Ključne riječi

obesity, GLP-1 receptor agonist, semaglutide

Hrčak ID:

345475

URI

https://hrcak.srce.hr/345475

Datum izdavanja:

5.3.2026.

Podaci na drugim jezicima: hrvatski

Posjeta: 245 *